PMGC Holdings Inc. (ELAB) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Newport Beach, CA, 美国. 现任CEO为 Graydon Bensler.
ELAB 拥有 IPO日期为 2023-11-21, 2 名全职员工, 在 NASDAQ Capital Marke, 市值为 $8.13M.
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
